Arca Biopharma | ABIO - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Amgen USD 6.89B 415M 2025-12
Arca Biopharma 0 0 2025-03
Biogen USD 1.82B 169.5M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Capricor Therapeutics 11.13M 8.87M 2024-12
Cipla INR 39.1B 2.54B 2026-03
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 63.8M 63.56M 2025-12
CSL USD 4.46B 2.71B 2025-12
Cytokinetics USD 19.2M 1.44M 2026-03
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Grifols EUR 766.49M 39.74M 2024-12
Laboratory Of America USD 1.01B 20.6M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Otsuka Holdings JPY 456.25B 1.16B 2026-03
Pfizer USD 11.04B 1.24B 2026-03
United Therapeutics USD 315.5M 286.6M 2025-12